Skip to content

Europe Has Its Own Biotech Star as Argenx Soars on Trial Success · Stateside Daily

Stateside DailyAll America

Search Get alerts

Home›Markets›1 sources

Markets · 1 sources covering this

Europe Has Its Own Biotech Star as Argenx Soars on Trial Success

It’s been a big week for biotech stocks on both sides of the Atlantic.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
Europe Has Its Own Biotech Star as Argenx Soars on Trial Success
It’s been a big week for biotech stocks on both sides of the Atlantic.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/46381b6744c119bc7fee485fa849f308de34c71c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Europe Has Its Own Biotech Star as Argenx Soars on Trial Success"></iframe>

More from Markets

BloombergLean L·55m ago

Hua Medicine CEO Li Chen on Earnings

BloombergLean L·58m ago

T. Rowe Price Says Nigeria Attractive Even After 64% Stock Rally

Daily briefing

Stateside Daily in your inbox

The 5 stories from all america you actually need to read. Once a day, no fluff. Unsubscribe in one click.

Stateside Daily

About
Methodology
Sources
Careers
Contact
Editorial standards

Sections

Politics
Business
Markets

BloombergLean L·1h ago

Goldman Says Slowing Inflation Is Best Path to Lower US Yields

BloombergLean L·1h ago

Goldman Muscles Into Indian Banks’ Turf With State Share Deals

Reader

Today's briefing
Archive
Topics
Editorial guides
Notifications
Embed widgets
Bookmarks
Search

Trust & legal

Coverage stats
Corrections
Privacy
Terms
Security

Across the network

Hindustan Sphere
All India in one feed

© 2026 Stateside Daily. All headlines are sourced from third-party publishers; we never republish article bodies.

All America